FDA Approves AbbVie (ABBV) VENCLEXTA and Acalabrutinib Combination for First-Line CLL

24 2 月, 2026

One Min Read

7 Views

原文: https://finance.yahoo.com/news/fda-approves-abbvie-abbv-venclexta-071108164.html

Last Update: 24 2 月, 2026

Written By

Other Articles

Previous

A股馬年開門紅滬指升0.87%

Next

British American Tobacco (BTI) Reports 2025 Revenue, Profit Growth Driven by Smokeless Categories

Related Posts

Powerball jackpot soars to $1.3 billion. Here’s what the winner will take home after taxes.

1 Min Read

What is force-placed car insurance, and when do lenders require it?

1 Min Read

Do you need collateral for a personal loan? See when it might help.

1 Min Read

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept